5,305 Shares in CME Group Inc. $CME Bought by Raleigh Capital Management Inc.

Raleigh Capital Management Inc. purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 4th quarter, HoldingsChannel reports. The firm purchased 5,305 shares of the financial services provider’s stock, valued at approximately $1,449,000.

Several other institutional investors have also added to or reduced their stakes in CME. Sanders Capital LLC purchased a new stake in CME Group during the third quarter valued at about $1,006,932,000. Strive Asset Management LLC purchased a new stake in CME Group during the third quarter valued at about $636,487,000. Mawer Investment Management Ltd. boosted its position in CME Group by 107.2% during the third quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock valued at $406,029,000 after buying an additional 777,571 shares during the period. Viking Global Investors LP purchased a new stake in CME Group during the second quarter valued at about $164,648,000. Finally, Invesco Ltd. boosted its position in CME Group by 23.0% during the third quarter. Invesco Ltd. now owns 2,830,323 shares of the financial services provider’s stock valued at $764,725,000 after buying an additional 528,358 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $308.57 on Tuesday. The company has a market cap of $110.66 billion, a price-to-earnings ratio of 27.65, a price-to-earnings-growth ratio of 3.25 and a beta of 0.26. The company has a 50-day moving average price of $305.20 and a 200-day moving average price of $283.58. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $248.53 and a 12 month high of $329.16.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm posted $2.52 earnings per share. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th were paid a dividend of $1.30 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend was Tuesday, March 10th. CME Group’s payout ratio is 46.59%.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 4,200 shares of the stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the sale, the director owned 43,007 shares in the company, valued at $13,317,117.55. This represents a 8.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Dennis Suskind sold 748 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the sale, the director owned 2,699 shares in the company, valued at approximately $809,700. The trade was a 21.70% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 8,539 shares of company stock worth $2,713,821 over the last three months. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on CME shares. UBS Group restated a “neutral” rating and set a $310.00 price target on shares of CME Group in a research report on Friday, February 6th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Raymond James Financial upped their price target on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research report on Monday. Rothschild & Co Redburn upped their price target on shares of CME Group from $333.00 to $347.00 and gave the company a “neutral” rating in a research report on Thursday, March 12th. Finally, The Goldman Sachs Group upped their price objective on shares of CME Group from $266.00 to $275.00 and gave the company a “sell” rating in a research note on Monday, March 16th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $304.65.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.